JPS61233697A - Production of nicotinamide adenine dinucleotide phosphate - Google Patents

Production of nicotinamide adenine dinucleotide phosphate

Info

Publication number
JPS61233697A
JPS61233697A JP7259385A JP7259385A JPS61233697A JP S61233697 A JPS61233697 A JP S61233697A JP 7259385 A JP7259385 A JP 7259385A JP 7259385 A JP7259385 A JP 7259385A JP S61233697 A JPS61233697 A JP S61233697A
Authority
JP
Japan
Prior art keywords
adenine dinucleotide
nicotinamide adenine
phosphate
nad
kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7259385A
Other languages
Japanese (ja)
Other versions
JPH0559711B2 (en
Inventor
Yukiharu Kobayashi
行治 小林
Kanji Koyashiki
小屋敷 勘治
Toyofumi Miya
豊文 美矢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kohjin Holdings Co Ltd
Kohjin Co
Original Assignee
Kohjin Holdings Co Ltd
Kohjin Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kohjin Holdings Co Ltd, Kohjin Co filed Critical Kohjin Holdings Co Ltd
Priority to JP7259385A priority Critical patent/JPS61233697A/en
Publication of JPS61233697A publication Critical patent/JPS61233697A/en
Publication of JPH0559711B2 publication Critical patent/JPH0559711B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

PURPOSE:To obtain inexpensively and efficiently the titled compound useful as a biochemical analysis reagent, etc., from nicotinamide adenine dinucleotide, acetyl phosphate and adenosine 5'-monophosphate, by using a bacterum having specific enzymatic activity. CONSTITUTION:A solution such as phosphoric acid buffer solution, etc. is blended with 0.5-20 mg/ml nicotinamide adenine dinucleotide(NAD), 0.003-1.0 mg/ml adenosine 5'-monophosphate(AMP) and 0.14-5.8 mg/ml acetyl phosphate(ACP) in preferable concentrations (usually AMP/NAD is <=1/10 equivalent) and reacted with a mold of bacterium [e.g., Brevibacterium ammoniagenes(ATCC15312), etc.] having enzymatic activities of NAD kinase, acetate kinase and adnylate kinase under preferable conditions at 5.0-9.0 pH at 15-50 deg.C to give the aimed compound.

Description

【発明の詳細な説明】 (産業上の利用分野) ニコチンアミド・アデニン・ジヌクレオチド・フォスフ
ェート(以下NAI)Pと略す)はニコチンアミド・ア
デニン・ジヌクレオチド(以下NADと略す)と共に生
体内において酸化還元反応を司る酵素1例えば、グルコ
ース・6−リン醪脱水素酵素、グルタミン酸脱水素酵素
、6−ホスホグルコン酸脱水素酵素などの補酵素として
古くから知られている重要な物質であり、生化学用分析
試薬や臨床検査片診断薬のみならず食品中のブドウ糖や
グルコン酸の測定など食品分骨にも広く利用されている
。更に今日ではバイオリアクターによるアミノ酸などの
有用物質の生産にN A 1.)やNADPの再生系と
の共役が試みられ注目を集めている有用な物質である。
Detailed Description of the Invention (Field of Industrial Application) Nicotinamide adenine dinucleotide phosphate (hereinafter abbreviated as NAI) is used in vivo together with nicotinamide adenine dinucleotide (hereinafter abbreviated as NAD). Enzyme 1 that governs redox reactions It is an important substance that has long been known as a coenzyme, such as glucose 6-phosphorus dehydrogenase, glutamate dehydrogenase, and 6-phosphogluconate dehydrogenase. It is widely used not only as chemical analytical reagents and diagnostic reagents for clinical test strips, but also for measuring glucose and gluconic acid in food. Furthermore, today, bioreactors are used to produce useful substances such as amino acids. ) and NADP regeneration systems, and it is a useful substance that is attracting attention.

(従来の技術) (1) N A D Pは従来より酵母からの抽出法に
より製造されてきた。
(Prior Art) (1) N A D P has conventionally been produced by an extraction method from yeast.

(2)近年、NAI)キナーゼ活性を有する微生物によ
りNADとアデノシントリ・フォスフェート(以下AT
Pと略す)からNADPを製造する方法(特公昭47−
46858.%開昭50−18.5290.特開昭5O
−142792)が開発された。(反応式]) (3)また、アデニレートキナーゼによるエネルギー共
役系を利用する方法(特開昭58−11.5891)も
ある。(反応式2) (4)一方、ATPを再生する系として、(反応式3)
に示すようにACPとアセテートキナーゼを利用する方
法も有効であることが報告さ扛ている。(丸尾、 FF
I宮監修「酵素ハンドブック」。
(2) In recent years, microorganisms with NAI) kinase activity have been used to synthesize NAD and adenosine triphosphate (AT).
Method for producing NADP from (abbreviated as P)
46858. % Kaisho 50-18.5290. Tokukai Showa 5O
-142792) was developed. (Reaction formula) (3) There is also a method using an energy coupled system using adenylate kinase (Japanese Unexamined Patent Publication No. 58-11-5891). (Reaction formula 2) (4) On the other hand, as a system for regenerating ATP, (Reaction formula 3)
As shown in Figure 2, a method using ACP and acetate kinase has also been reported to be effective. (Maruo, FF
``Enzyme Handbook'' supervised by Inomiya.

朝倉書店、  P367.1983)更に、この反応′
(!7N A ]’) ’P生成反応に使用した例とし
てニワトリの肝臓と大腸菌からそれぞれ単離し精製した
N A、 Dキナーゼとアセテートキナーゼを甲いたミ
ャワキらの報告がある。(0sato M 1yaia
kiet、 at、 、 Agric、 f3ioL 
Chem、、 Vol、 46+ 2725−2788
゜1.982 ) (発明が解決しようとする問題点) (])酵母からの抽出法では菌体内の蓄槓惜が少なく大
量に得ることは困難である□ (2) N A DとA’rPから作る方法ではNAI
)と等モルの高価なATPを必要とする。
Asakura Shoten, P367.1983) Furthermore, this reaction'
(!7NA]') 'Myawaki et al. reported that they used NA and D kinases and acetate kinases isolated and purified from chicken liver and Escherichia coli, respectively, as examples of their use in P production reactions. (0sato M 1yaia
kiet, at, , Agric, f3ioL
Chem,, Vol, 46+ 2725-2788
゜1.982) (Problems to be solved by the invention) (]) With the extraction method from yeast, it is difficult to obtain a large amount because there is little accumulation in the bacterial body □ (2) N A D and A' In the method of making from rP, NAI
) and require equimolar amounts of expensive ATP.

(3)エネルギー共役系を利用する場合でもNA、D1
モルにつき0.5モルのATPが必要でありそれitど
有利とは言えない。
(3) Even when using an energy conjugated system, NA and D1
0.5 mole of ATP per mole is required, which is not particularly advantageous.

(4)各酵素を単離して用いる方法は繁雑であり、かつ
安定性に欠は工業的に有利とはいえない・(問題を解決
するための手段及び作用)本発明者らは上記の欠点を解
決するため鋭意検討した結果、NADキナーゼの反応に
よってNADとATPからNADPを生化学的に合成す
るに際し、NADキナーゼとアデニレート・キナーゼ及
びアセテート・キナーゼの酵素活性を同時に有するバク
テリアを用いれば、そ扛ぞれの酵素を分離精製すること
々<、NADP合成反応とATP再生反応を同時に行い
得ることを見出した。すなわち菌体自身が有するアデニ
レート・キナーゼの作用によりAMPからA I) P
を生成せしめ1次にアセテート・キナーゼによりACP
とADPからATPを生成するとともにこのとのATP
をNADPの生成合成反応に使用し、更に生じたA D
 Pは再度A、 CPとアセテート・キナーゼの作用に
よりA TP [繰返し変換できること、加えて都合の
良いことには反応開始に必ずしも高価なATPを必要と
せず、より安価なAヤIPが使用できること。
(4) The method of isolating and using each enzyme is complicated and lacks stability, so it cannot be said to be industrially advantageous. (Means and effects for solving the problem) The present inventors have identified the above drawbacks. As a result of intensive studies to solve this problem, we found that when biochemically synthesizing NADP from NAD and ATP through the reaction of NAD kinase, it is possible to do so by using bacteria that simultaneously have the enzymatic activities of NAD kinase, adenylate kinase, and acetate kinase. We have discovered that it is possible to perform the NADP synthesis reaction and the ATP regeneration reaction simultaneously by separating and purifying each enzyme. In other words, AMP is converted to A by the action of the adenylate kinase of the bacterial cell itself.
ACP is first generated by acetate kinase.
Generates ATP from and ADP, and also generates ATP from this and
was used in the synthesis reaction to produce NADP, and the resulting A D
P can be converted into A TP again by the action of A, CP and acetate kinase, and the advantage is that the expensive ATP is not necessarily required to initiate the reaction, and the cheaper AyaIP can be used.

しかも10分の1モル当量り下の添加でも反応が進むこ
とを見出し1本発明を光成するに至った。
Furthermore, they discovered that the reaction proceeded even when the amount was added at a level lower than 1/10 of a molar equivalent, leading to the completion of the present invention.

次に2本発明について詳述する。本発明に言うNA、D
キナーゼ、アセテートキナーゼ、及びアデニレートキナ
ーゼの酵素活性を有するバクテI77としては、バチル
ス属、プレビバクテυ五つム属。
Next, two aspects of the present invention will be described in detail. NA, D according to the present invention
Examples of Bacterium I77 having enzyme activities of kinase, acetate kinase, and adenylate kinase include Bacillus and Previbacte quintatum.

コリネバクテリュウム属、アルカリ土類金属、アースロ
バクルー属、 エシェリヒア属、プロテウス属、シュウ
トモナス属、サルシナ稠、セラチア属などが挙げられる
。また、これらのバクテリアを二神類以上組合わせても
よい。
Examples include Corynebacterium, alkaline earth metals, Arthrobacillus, Escherichia, Proteus, Shutomonas, Sarcinus, and Serratia. Furthermore, two or more types of these bacteria may be combined.

一例をあげれば、ブレビバクテリウム・アンモニアゲネ
ス(ATCC15812)を常法に従って培養し菌体を
取得する。該菌体を必要に応じて洗浄し、そのまま、ま
たはアクリルアミドやアルギン酸等のゲルに固定化した
固定化菌体を用いる。
For example, Brevibacterium ammoniagenes (ATCC 15812) is cultured according to a conventional method to obtain bacterial cells. The cells are washed if necessary, and used as they are, or as immobilized cells that have been immobilized on a gel such as acrylamide or alginic acid.

このとき菌体若しくは、固定化菌体を有機浴剤や界面活
性剤を接触させて菌体の酵素活性を高めた後使用するこ
ともできる。反応液中の基質濃度はN A D 0.5
〜20 mVml、 A M P 0.008〜1. 
OTng汐、ACPO,14〜5.84匂の範囲が望捷
しく更にマグネシウムやマンガン塩等の酵素活性剤を必
要に応じて添加する。ACPとしては無水酢酸とリン酸
塩とを反応させて生成したACPを反応液の1捷添加し
てもよい。菌体濃度は5〜50〜鷹の範囲が好ましく1
反応は適当な緩衝液9例えば、リン酸緩衝液により行う
。反応はpH5,0〜90、反応温度は15〜50°C
が望捷しい。反応援は、菌体を分離し、常法に従いイオ
ン交換樹脂等により分離精製する。
At this time, the bacterial cells or immobilized bacterial cells may be brought into contact with an organic bath agent or a surfactant to increase the enzymatic activity of the bacterial cells before use. The substrate concentration in the reaction solution is NAD 0.5
~20 mVml, AMP 0.008-1.
OTng, ACPO, a range of 14 to 5.84 odor is desirable, and an enzyme activator such as magnesium or manganese salt may be added as necessary. As the ACP, ACP produced by reacting acetic anhydride with a phosphate may be added to one portion of the reaction solution. The bacterial cell concentration is preferably in the range of 5 to 50 to 1
The reaction is carried out using a suitable buffer 9, such as a phosphate buffer. Reaction pH 5.0-90, reaction temperature 15-50°C
is promising. For anti-cheating, bacterial cells are separated and purified using an ion exchange resin or the like according to a conventional method.

(実施例) 以下9本発明の実施例を示すが、何ら本発明を限定する
ものではない。
(Example) Nine examples of the present invention are shown below, but the present invention is not limited to the present invention in any way.

実施例 l プレビバクテリュウム・アンモニアゲネス(ATCo 
15812)をグルコース1%、イーストエキス1%、
ペプトン1%の培地で80°C124時間培#L、遠心
分離法により集菌し、乾燥菌体量が20〜4eとなるよ
うに20 mM塩什マンガンを含む0.2 M 17ン
酸緩f#液(pH7,5)に懸濁する(Mけ7モル/l
の濃度1口]Mは1000の濃度を示す。)。本液に対
液41%のトルエンを加え室温で1時間攪拌後遠心分離
法により集菌し、再び乾燥菌体量が、20■41となる
ように20+nM塩化マンガンを含む02Mリンリン酸
緩衝液H7゜5)。
Example l Previbacterium ammoniagenes (ATCo
15812) with 1% glucose, 1% yeast extract,
Culture #L at 80°C for 124 hours in a medium containing 1% peptone. Collect bacteria by centrifugation, and add 0.2 M 17 phosphoric acid buffer containing 20 mM manganese chloride so that the dry cell mass is 20 to 4. # Suspend in solution (pH 7.5) (Make 7 mol/l
concentration of 1 sip] M indicates a concentration of 1000. ). To this solution, add 41% toluene to the solution, stir for 1 hour at room temperature, collect bacteria by centrifugation, and add 02M phosphoric acid buffer H7 containing 20+nM manganese chloride so that the dry cell mass is 20 x 41.゜5).

N A、 I) 4.0 mvlnl、 A、MP 0
.03”!/me、 A CP 1.21n7!を加え
、87rで6時間反応した。反応液中に生成したNAD
Pは8.91^eであった。
N A, I) 4.0 mvlnl, A, MP 0
.. 03”!/me, A CP 1.21n7! was added and reacted at 87r for 6 hours. NAD generated in the reaction solution
P was 8.91^e.

実施例 2 実施例1と同様にして得られたブレビバクテリウム・ア
ンモニアゲネス(ATCC15B 1.2)(湿潤菌体
として)17vを凹部の1℃食塩水に懸濁し4(1℃に
加温後、3%1(−カラギーナンを含む1%食塩水d′
eをl:1の液比で混合し2て0゜3M塩化カリウム水
溶液に滴下しゲル化した。本固定化菌体を20mM塩化
マンガンを含む(1,2Mリン酸緩衝液(pH7,5)
に懸濁し、実施例■と同様にトルエン処理して固定体菌
体68ノを得た。
Example 2 17v of Brevibacterium ammoniagenes (ATCC15B 1.2) (as a wet bacterial cell) obtained in the same manner as in Example 1 was suspended in a 1°C saline solution in a concave portion, and the suspension was heated to 4°C (after heating to 1°C). , 3% 1 (-1% saline solution containing carrageenan d'
The mixture was mixed at a liquid ratio of 1:1 and added dropwise to a 0°3M potassium chloride aqueous solution to form a gel. This immobilized bacterial cell was dissolved in a 1.2M phosphate buffer (pH 7.5) containing 20mM manganese chloride.
and treated with toluene in the same manner as in Example ① to obtain 68 fixed cells.

本国9(1[体eNA D 4.Oq/mz、 A M
P O,08nVrn1. A CP 1.2 mt4
e及び20 mMi−z化マンガンを含む0.2 M 
IIン酸緩衝液に懸濁l−で37°C,6時間反応させ
る。反応終了後生成したN A i) Pは2、5 m
gAne ’11’あツタ。
Home country 9 (1 [body eNA D 4.Oq/mz, A M
P O,08nVrn1. A CP 1.2 mt4
0.2 M containing e and 20 mM manganese
Suspend in II phosphate buffer and react at 37°C for 6 hours. N A i) P produced after the reaction is 2.5 m
gAne '11' Atsuta.

実施例 8 2.5Mのリン酸21カリウム溶#′40−に水2〇−
を加え4・規定濃度の水酸化カリウムによりpH=6.
0〜7.0に調整しつつ無氷酢酸1 ]、 mlを徐々
に滴下した。水冷下1時間攪拌した後、水を加え■00
−に合わせた。この反応液中にはA、 CPが80 w
vmt、含有されていた。
Example 8 2.5M 21potassium phosphate solution #'40- to water 20-
4. Adjust the pH to 6 with potassium hydroxide at the specified concentration.
1 ml of ice-free acetic acid was gradually added dropwise while adjusting the concentration to 0 to 7.0. After stirring for 1 hour under water cooling, water was added ■00
- adjusted. This reaction solution contains 80 w of A and CP.
vmt, contained.

別にブレビバクテリウム・アンモニアゲネス(ATCC
l 5812)とエシェリヒア・コリBi各々グルコー
ス1%、ペプトン1%、イーストエキス1%を含む培地
で培養しく湿潤菌体として)5fづつを混合し、水冷下
30%塩化カリウム5゜4m1.83.5%アクリルア
ミド5.4m1. 5%β−ジメチルアミノプロピオネ
ート1.8d、6.5%過硫酸アンモニウム2.1 +
++/を加え加温し固化し、固定什菌体802を州だ。
Separately, Brevibacterium ammoniagenes (ATCC
5812) and Escherichia coli Bi (as moist bacterial cells cultured in a medium containing 1% glucose, 1% peptone, and 1% yeast extract) were mixed together, and 5°4 ml 1.83ml of 30% potassium chloride was mixed under water cooling. 5% acrylamide 5.4ml 1. 5% β-dimethylaminopropionate 1.8d, 6.5% ammonium persulfate 2.1 +
++/ was added and heated to solidify, leaving 802 fixed bacterial cells.

本菌体をトルエン8%を含む5 mM’ ) ’)スー
塩酸緩衝液(pH’7.0 )に幡濁し、25°C2■
時間振とうし活性化した。
The bacterial cells were suspended in 5 mM')') HCl buffer (pH'7.0) containing 8% toluene, and incubated at 25°C.
Activated by shaking for an hour.

本固定化菌体をNAI) 4.0 mg/me、 A−
M P 0.08^e、上記で得たACP合成反応液(
ACPとして80 m@/me) 0.0 ]、 5q
ptJ/atl及び2 OmMfg化マグ反応終了後生
成したN A D I)け]、、 8 ’q/meであ
った。
This immobilized bacterial cell is NAI) 4.0 mg/me, A-
M P 0.08^e, ACP synthesis reaction solution obtained above (
80 m@/me) 0.0 ], 5q as ACP
ptJ/atl and 2 OmMfg formed after the MAG reaction was completed.

(効果) 以上のように本発明においては、牟離した酵素を組合わ
せて用いないで必要な酵素活性を同時に有するバクテリ
アを用いることによりリン酸化原オー1として高価なA
TPを用いないでもより安価なAMP及びA、 CPに
より、珪AMPはN A D ]モル当り10分の1モ
ル以下の添加にまり安1曲に。
(Effects) As described above, in the present invention, instead of using a combination of separated enzymes, by using bacteria that simultaneously have the necessary enzyme activity, the expensive A
By using AMP, A, and CP, which are cheaper even without using TP, silicon AMP can be added at less than 1/10 mole per mole of N A D and only one mariyasu is added.

且@率よ(NAI)Pi!J造することができる。And @Rateyo (NAI) Pi! It is possible to build J.

Claims (4)

【特許請求の範囲】[Claims] (1)ニコチンアミド・アデニン・ジヌクレオチド・キ
ナーゼとアセテートキナーゼおよびアデニレートキナー
ゼの酵素活性を共に有する一種類以上のバクテリアを用
いてニコチンアミド・アデニン・ジヌクレオチドとアセ
チルリン酸及びアデノシン5′−モノリン酸からニコチ
ンアミド・アデニン・ジヌクレオチド・フォスフェート
を製造する方法。
(1) Nicotinamide adenine dinucleotide, acetyl phosphate and adenosine 5'- A method for producing nicotinamide adenine dinucleotide phosphate from monophosphoric acid.
(2)バクテリア菌体をそのまま懸濁の状態で用いるか
、もしくは担体に固定化して用いる特許請求範囲第1項
記載のニコチンアミド・アデニン・ジヌクレオチド・フ
ォスフェートを製造する方法。
(2) A method for producing nicotinamide adenine dinucleotide phosphate according to claim 1, in which bacterial cells are used as they are in suspension or are immobilized on a carrier.
(3)アセチルリン酸として、無水酢酸とリン酸塩とを
反応させて生成したものを反応液のまま用いることを特
徴とする特許請求範囲第1項記載のニコチンアミド・ア
デニン・ジヌクレオチド・フォスフェートを製造する方
法。
(3) Nicotinamide adenine dinucleotide phos according to claim 1, characterized in that as the acetyl phosphoric acid, a product produced by reacting acetic anhydride and a phosphate is used as a reaction solution. How to make fetes.
(4)アデノシ5′−モノリン酸をニコチンアミド・ア
デニン・ジヌクレオチドに対して10分の1モル当量以
下を添加することを特徴とする特許請求範囲第1項記載
のニコチンアミド・アデニン・ジヌクレオチド・フォス
フェートを製造する方法。
(4) Nicotinamide adenine dinucleotide according to claim 1, characterized in that adenosy 5'-monophosphoric acid is added in an amount of 1/10 molar equivalent or less to nicotinamide adenine dinucleotide.・Method of producing phosphate.
JP7259385A 1985-04-08 1985-04-08 Production of nicotinamide adenine dinucleotide phosphate Granted JPS61233697A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7259385A JPS61233697A (en) 1985-04-08 1985-04-08 Production of nicotinamide adenine dinucleotide phosphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7259385A JPS61233697A (en) 1985-04-08 1985-04-08 Production of nicotinamide adenine dinucleotide phosphate

Publications (2)

Publication Number Publication Date
JPS61233697A true JPS61233697A (en) 1986-10-17
JPH0559711B2 JPH0559711B2 (en) 1993-08-31

Family

ID=13493847

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7259385A Granted JPS61233697A (en) 1985-04-08 1985-04-08 Production of nicotinamide adenine dinucleotide phosphate

Country Status (1)

Country Link
JP (1) JPS61233697A (en)

Also Published As

Publication number Publication date
JPH0559711B2 (en) 1993-08-31

Similar Documents

Publication Publication Date Title
Wong et al. Enzyme-catalyzed organic synthesis: NAD (P) H cofactor regeneration by using glucose-6-phosphate and the glucose-5-phosphate dehydrogenase from Leuconostoc mesenteroides
WO2011110056A1 (en) Method for microbial production of cyclic adenosine 3&#39;, 5&#39;-monophosphate
Walt et al. An efficient chemical and enzymic synthesis of nicotinamide adenine dinucleotide (NAD+)
EP0385486B1 (en) Process for producing fructose-1,6-diphosphate
JP3098591B2 (en) Method for producing 3&#39;-phosphoadenosine-5&#39;-phosphosulfate
JPH0234599B2 (en)
US4385112A (en) Nucleoside oxidase and process for making same, and process and kit for using same
JPS61233697A (en) Production of nicotinamide adenine dinucleotide phosphate
JP3080771B2 (en) Method for producing dinucleoside polyphosphate or derivative thereof
JPS5922516B2 (en) Method for producing L-phenylalanine
JPS6350359B2 (en)
Woenckhaus et al. Preparations of holodehydrogenases by covalent fixation of NAD+-analogs to alcohol and lactate dehydrogenase
JPH0265787A (en) Production of l(-)-tetrahydrofolic acid
JPS6314956B2 (en)
JPH01320995A (en) Production of nucleoside compound
JPH0231686A (en) Production of trifluorothymidine
JPH0669387B2 (en) Process for producing S-adenosylmethionine
JPH04126099A (en) Highly sensitive determination method of myoinositol and composition for determination
JPS5834118B2 (en) Nicotinamide Adenine Dinucleotide Phosphate
JPH0424992B2 (en)
JPH05137572A (en) Thermostable adenosine-5&#39;-triphosphate sulfurylase and its production
JPH0591895A (en) Production of d-serine
JPS5931700A (en) Determination of organism substance producing ammonia as reaction product
JPS58146286A (en) Preparation of selenium-containing amino acid
JPS62181782A (en) Increasing of enzymic activity

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees